Pain therapy

Cannabis and Cannabinoids: Pharmacology, Toxicology, and Therapeutic Potential

Volumn , Issue , 2013, Pages 181-186

  Holdcroft, Anita ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 4043065459     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (24)

1. Cancer Pain Relief Geneva: World Health Organization, 1986, p. 51
2. Cannabis: The scientific and medical evidence. Select Committee on Science and Technology. House of Lords, 9th Report session, 1997-98. London: The Stationery Office, 1998
3. Davies BH, Weatherstone R1v1, Graham IDP, Griffiths RD. A pilot study of orally administered delta-l-(trans)-tetrahydrocaImabinol in the management of patients undergoing radiotherapy for carcinoma of the bronchus. British Journal of Pharmacology 1974;1:301-306
4. Dunn M, Davis R. The perceived effects of marijUaIla on spinal cord injured males. Paraplegia 1974:12(3):175
5. Fields HL, ed. Core curriculumfor professional education. International Association for the Study of Pain. Seattle, WA: IASP Press,1991, p. 28
6. Finnegan-Ling D, Musty RE. Marinol and phantom limb pain; a case study. In 1994 Symposium on the Cannabinoids. Burlington, VT: International Cannabinoid Research Society, 1994, p. 53
7. Grinspoon L, Bakalar lB. Marihuana, the forbidden medicine. New Haven, CT: Yale University Press, 1993
8. Hill SY, Goodwin DW, Schwin R, Powell B. Marihuana: eNS depressant or excitantO American JOllrnal of Psychiatry 1974; 131 (3):313-315
9. Hill SY, Schwin R, Goodwin DW, Powell B. Marihuana and pain. Journal of Pharmacology alld Experimental Therapeutics 1974;188(2):415-418
10. Holdcroft A, Smith M, Jacklin A, Hodgson H, Smith B, Newton M, Evans F. Pain relief with oral cannabinoids in familial Mediterranean fever. Anaesthesia 1997;52(5):483-488
11. Holdcroft A, Smith M, Smith B, Hodgson H, Evans F. Clinical trial experience with cannabinoids. Pharmaceutical Science 1997;3:546-550
12. Jaggar SI, Hasnie FS, Sellaturay S, Rice ASC. The anti-hyperalgesic actions of the cannabinoid anandamide and the putative eB2 receptor agonist pabnitoylethanolamide in visceral and somatic inflammatory pain. Pain 1998;76(1-2):189-199
13. Jain AK, Ryan JR, McMahon FG, Smith G. Evaluation of intramuscular levonantrodol and placebo in acute postoperative pain. Journal afClinical Phannacology 1981 ;21(Suppl):320S-326S
14. Karniol IG, Shirakawa I, Takahashi RN, Knobel E, Musty RE. Effects of delta-9 tetrahydrocamlabinol and cannabinol in man. Pharmacology 1975;13(6): 502-512
15. Lichtman AH, Martin BR. Spinal and supraspinal components of cannabinoid-induced antinociception. Journal of Pharmacology alld Experimelltal Therapelltics 1991:258(2):517-523
16. Maurer M, Henn V, Dittrich A, HofmannA. Delta-9-THC shows antispastic and analgesic effects in a single case double blind trial. European Archives of Ps.vchiatry and Clinical Neuroscience 1990;240(1): 1-4
17. Mechoulam R. The pharmacology of Cannabis sativa. In Mechoulam R, ed. Cannabinoids as therapeutic agents. Boca Raton, FL: eRe Press, 19R6
18. Mersky H, Bogduk N, eds. Classijication afChronic Pain. Descriptions of chronic pain syndromes and definition afpain terms. International Association for the Study of Pain. Seattle, W A: IASP Press, 1994
19. Noyes R, Brunk SF, Bararn DA, Canter A. Analgesic effects of delta-9-THC. Journal of Clinical Pharmacology 1975: 15(2-3): 139-143
20. Noyes R, Brunk SF, Avery DH, Canter A. The analgesic properties of delta-9-tetrahydrocannabinol and codeine. Clinical Pharmacology and Therapeutics 1975: 18(1 ):84-89
21. Raft D, Gregg J, Ghia J, Hanis L. Effects of intravenous tetrahydrocannabinol on experimental and surgical pain: Psychological correlates of the analgesic response. Clinical Pharmacology and Therapeutics 1977;21 (1):26-33
22. Reynolds JR. Therapeutic uses and toxic effects of Cannabis indica. Lancet 1890:1:637-638
23. Richardson JD, Kilo S, Hargreaves KM. Call1labinoids reduce hyperalgesia and inflammation via interaction with peripheral eB I receptors. Pain 1998;75(1): 111-119
24. Welch SP, Stevens DL. Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine in mice. Journal of Pharmacology and Experimental Therapeutics 1992;262( 1):10-18